Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients

Journal of Controlled Release

Volumn 60, Issue 2-3, 1999, Pages 333-341

  Thombre, A G ^a   DeNoto, A R ^a   Gibbes, D C ^a  

^a PFIZER INC   (United States)

Author keywords

Asymmetric membrane capsules; Encapsulated excipients; Glipizide; Osmotic delivery

Indexed keywords

ACETONE; ALCOHOL; CELLULOSE ACETATE; CITRIC ACID TRIETHYL ESTER; DYE; GLIPIZIDE; GLYCEROL; HYDROXYPROPYLCELLULOSE; LACTOSE; MEGLUMINE;

ARTICLE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; IN VITRO STUDY; PH; PRIORITY JOURNAL;

CAPSULES; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GLIPIZIDE; HYDROGEN-ION CONCENTRATION; MEMBRANES, ARTIFICIAL; OSMOSIS; SOLUBILITY; TIME FACTORS;

EID: 0032765727     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00086-3     Document Type: Article

References (11)

1. Theeuwes F. Elementary osmotic pump. J. Pharm. Sci. 64:1975;1987-1991.
2. Zentner G.M., Rork G.S., Himmelstein K.J. The controlled porosity osmotic pump. J. Control. Release. 1:1985;269-282.
3. R.W. Baker, J.W. Brooke, Pharmaceutical drug delivery system, US Patent No. 4,687,660 (1987).
4. Lindstedt B., Sjorberg M., Hjarstam J. Osmotic pumping release of KCl tablets with porous and non-porous ethylcellulose. Int. J. Pharm. 67:1991;21-27.
5. Herbig S.M., Cardinal J.R., Korsmeyer R.W., Smith K.L. Asymmetric-membrane tablet coatings for osmotic drug delivery. J. Control. Release. 35:1995;127-136.
6. F. Theeuwes, Osmotic system for delivering selected beneficial agents having varying degrees of solubility, US Patent No. 4,111,201.
7. A.L. Kuczynski, A.D. Ayer, P.S. Wong, Dosage form for administering oral hypoglycemic glipizide, US Patent No. 5,545,413.
8. Thombre A.G., Cardinal J.R., DeNoto A.R., Herbig S.M., Smith K.L. Asymmetric membrane capsules for osmotic drug delivery I. Development of a manufacturing process. J. Control. Release. 57:1999;55-64.
9. Thombre A.G., Cardinal J.R., DeNoto A.R., Gibbes D.C. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J. Control. Release. 57:1999;65-73.
10. a listing of medicinal compounds. Drug Intell. Clin. Pharm. 20:1986;683-686.
11. Zentner G.M., McClelland G.A., Sutton S.C. Controlled porosity solubility- and resin-modulated drug delivery systems for release of diltiazem hydrochloride. J. Control. Release. 16:1991;237-244.